Here's Why Encompass Health (EHC) is a Strong Growth Stock

Encompass Health (EHC), a prominent provider of inpatient rehabilitation services, is identified by Zacks as a strong growth stock, holding a Zacks Rank #2 (Buy) with an 'A' VGM Score and 'B' Growth Style Score. This assessment is supported by a forecasted 17.6% year-over-year earnings growth for the current fiscal year, alongside recent upward revisions by seven analysts for fiscal 2025 earnings, pushing the Zacks Consensus Estimate to $5.21 per share, and an average earnings surprise of +14%.

Analysis

Encompass Health (EHC) presents a strong growth profile according to Zacks' quantitative analysis, supported by multiple positive fundamental indicators. The company holds a Zacks Rank #2 (Buy), an 'A' for its composite VGM Score, and a 'B' for its Growth Score. This is underpinned by a forecast for 17.6% year-over-year earnings growth in the current fiscal year. Analyst sentiment appears robust, with seven upward earnings estimate revisions for fiscal 2025 over the last 60 days, which has elevated the consensus estimate by $0.20 to $5.21 per share. Furthermore, EHC has demonstrated a consistent ability to outperform expectations, evidenced by an average positive earnings surprise of 14%. The company's strategic position as a large-scale provider of inpatient rehabilitation services is noted as being well-aligned with the healthcare industry's shift towards integrated care and value-based payment models.

Key Decisions for Investors

• Given the strong growth forecast of 17.6% YoY earnings, positive analyst estimate revisions, and a history of significant earnings beats, growth-focused investors should consider EHC as a potentially attractive addition to their portfolios.
• It is crucial to monitor upcoming earnings releases to verify if the company's performance and forward-looking guidance continue to support the current bullish analyst consensus.
• Investors should recognize that this analysis is based on a specific quantitative model and should supplement it by evaluating broader industry risks, particularly potential changes in healthcare reimbursement policies that could impact EHC's revenue streams.